BioPharma Credit PLC (LON:BPCR)

BioPharma Credit Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 20, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	756	838	859	1,040	982	1,002
Market Cap Growth	-2.43%	-2.43%	-17.41%	5.90%	-2.00%	-5.28%
Enterprise Value	752	809	806	1,031	892	958
Last Close Price	0.67	0.67	0.56	0.59	0.47	0.45
PE Ratio	9.02	8.59	10.09	6.87	15.65	15.35
PS Ratio	6.31	7.00	8.06	5.74	12.80	12.44
PB Ratio	0.80	0.89	0.82	0.94	0.98	0.99
P/TBV Ratio	0.80	0.89	0.82	0.94	0.98	0.99
P/OCF Ratio	8.46	9.38	8.88	6.80	13.79	23.56
EV/Sales Ratio	6.75	6.75	7.56	5.70	11.62	11.88
EV/EBIT Ratio	8.29	8.29	9.46	6.82	14.21	14.67
Asset Turnover	0.12	0.12	0.10	0.16	0.08	0.08
Quick Ratio	2.09	2.09	9.79	5.34	16.51	20.60
Current Ratio	2.09	2.09	9.79	5.34	16.51	20.60
Return on Equity (ROE)	9.69%	9.69%	8.10%	13.50%	6.19%	6.41%
Return on Assets (ROA)	5.97%	5.97%	4.98%	8.33%	3.85%	3.96%
Return on Capital (ROIC)	6.05%	6.05%	5.06%	8.44%	3.87%	4.00%
Return on Capital Employed (ROCE)	10.30%	10.30%	8.10%	13.60%	6.20%	6.50%
Earnings Yield	12.90%	11.64%	9.91%	14.55%	6.39%	6.51%
Dividend Yield	11.24%	8.36%	9.87%	9.82%	10.88%	11.41%
Payout Ratio	89.23%	89.23%	63.58%	52.52%	113.20%	107.90%
Buyback Yield / Dilution	6.65%	6.65%	4.00%	0.72%	0.00%	0.00%
Total Shareholder Return	17.91%	15.01%	13.87%	10.54%	10.89%	11.41%

Updated Sep 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.